Literature DB >> 11025876

[A clinical study of posttraumatic hydrocephalus].

H Matsushita1, K Takahashi, Y Maeda, S Mandai, Y Gohda, M Kawauchi, Y Matsumoto.   

Abstract

From 1989 to 1998, 721 patients with head injury were admitted to our department and 22 (3.1%) of them developed posttraumatic hydrocephalus. These patients included 16 males and 6 females, ranging in age from 17 to 86 years (mean age, 66 yrs) with peak incidence in the eighth decade. CT scan on admission immediately after head injury showed subarachnoid hemorrhage (SAH) in 18 cases. The other 4 cases without SAH had once suffered head injuries severe enough to give rise to consciousness disturbance. The typical clinical symptoms of hydrocephalus were observed in only 5 (23%) patients, and in the other 17 cases prolonged or deteriorated of consciousness disturbance were the main symptoms. Hydrocephalus was diagnosed between 1 and 3 months in 15 cases and in 7 cases after 4 months. Clinical improvement has been seen in 17 (77%) cases and marked recovery of consciousness was achieved in 12 cases after V-P shunt, but 5 cases with severe disturbance of consciousness revealed no improvement of clinical signs even after decrease of ventricular size. These results indicate that elderly patients with traumatic SAH should be followed up for at least 4 to 5 months, paying attention to development of hydrocephalus, and V-P shunt would be effective to improve consciousness disturbance in most of the cases.

Entities:  

Mesh:

Year:  2000        PMID: 11025876

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  2 in total

1.  Post-traumatic hydrocephalus.

Authors:  Mohd Aidil Mohd Nor; Noor Azman Abdul Rahman; Johari Siregar Adnan
Journal:  Malays J Med Sci       Date:  2013-01

2.  Acute post-traumatic hydrocephalus in an infant due to aqueductal obstruction by a blood clot: a case report.

Authors:  Sunil Kumar Gupta; Tarun Sharma
Journal:  Childs Nerv Syst       Date:  2008-12-05       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.